title: Systemic proteolytic enzyme treatment diminishes urinary interleukin 6 in diabetic patients.
authors.forename: L
authors.initials: L
authors.lastname: Paczek
authors.forename: E H
authors.initials: EH
authors.lastname: Kropiewnicka
authors.forename: I
authors.initials: I
authors.lastname: Bartlomiejczyk
authors.forename: L
authors.initials: L
authors.lastname: Gradowska
authors.forename: A
authors.initials: A
authors.lastname: Heidland
authors.forename: G
authors.initials: G
authors.lastname: Wood
mesh_terms: D000368:Aged; D001963:Bromelains / Q000627:therapeutic use*; D003922:Diabetes Mellitus, Type 1 / Q000097:blood / Q000188:drug therapy* / Q000652:urine; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D015850:Interleukin-6 / Q000097:blood / Q000652:urine*; D008297:Male; D008875:Middle Aged; D010447:Peptide Hydrolases / Q000627:therapeutic use*; D012431:Rutin / Q000031:analogs & derivatives* / Q000627:therapeutic use; D014357:Trypsin / Q000627:therapeutic use*
chemical_list: D015850:Interleukin-6; C056067:rutin sulfate; D012431:Rutin; D001963:Bromelains; D010447:Peptide Hydrolases; D014357:Trypsin